期刊文献+

CHO细胞无血清培养基的工艺优化 被引量:1

Optimization of Serum-free Medium of CHO Cells
下载PDF
导出
摘要 本文以表达人肿瘤坏死因子受体-人Ig G-Fc抗体融合蛋白的CHO细胞为研究对象,通过对影响其细胞密度、活力及蛋白表达量和聚体百分比的进行了3个大类因素的考察,即水解物:0.5%酵母提取物,0.5%谷类水解物,0.5%大豆蛋白水解物,0.5%植物蛋白胨;脂类物质:10 mmol/L磷脂酰胆碱,10 mg/L乙醇胺,0.05%脂肪乳剂;激素类物质:10μmol/L氢化可的松(肾上腺皮质激素),10 mg/L胰岛素,20 n M孕酮(类固醇激素)。结果表明,水解物中0.5%酵母水解物,脂类物质中10 mg/L乙醇胺,激素类物质中10 mg/L胰岛素对提高CHO细胞密度、活力和蛋白表达量和降低聚体含量具有重要促进作用。 In this study,CHO cell,which can express antibody fusion protein of human tumor necrosis factor receptor-Fc- people Ig G,was used as research object. The effect of three important factors on the cell density,activity,expression level and percentage of polymers were investigated,including: the hydrolysate: 0. 5% yeast extract,0. 5% cereal hydrolysate,0. 5% soyprotein hydrolysate,0. 5% phytone; the lipid: 10 mmol / L phosphatidyl choline,10 mg / L ethanolamine,0. 05% intralipid; the hormone substances: 10 μmol / L hydrocortisone( adrenocortical hormone),10 mg / L insulin,20 n M progesterone( steroid hormones). The results showed that 0. 5% yeast hydrolysate,10 mg / L ethanolamine and0. 05% intralipid in lipid,10 mg / L insulin can significantly improve the density,activity and the protein expression level of CHO cells.
出处 《天然产物研究与开发》 CAS CSCD 北大核心 2016年第4期607-612,共6页 Natural Product Research and Development
基金 国家国际科技合作专项(2012DFA30910)
关键词 CHO细胞 无血清培养基 细胞活力 蛋白表达量 CHO cells serum free medium cell vitality protein expression level
  • 相关文献

参考文献16

  • 1Kaufman RJ, Sharp PA, Latt SA. Evolution of chromosomal regions containing transfeeted and amplified dihydrofolate rc- duetase sequences. Mol Cell Biol, 1983,3:699-711.
  • 2Grillberger L, Kreil TR, Nasr S, et al. Emerging trends in plasma - free manufacturing of recombinant protein therapeu- tics expressed in mammalian cells. Biotech J,2009,4:186- 201.
  • 3Zoon K. Points to Consider in the Characterization of Cell Lines Used to Produce Biologieals. Center for Biological E- valuation and Research, Roekville:Food and Drug Adminis- tration, 1993.7-8.
  • 4Schiff 13. Review: production, characterization, and testing ofbanked mammalian cell substrates used to produce biological produetsf. In Vitro Cell Dev-An,2005 ,41 (3-4) :65-70.
  • 5Van der Valk J,Mellor D,Brands R,et al. The humane cul- lection of fet al bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro,2004,18 ( 1 ) : 1-12.
  • 6Coeeke S,Balls M,Bowe G,et al. Guidance on good cell cul- ture practice, a report of the second ECVAM task force on good cell culture practice. Altern Lab Anita, 2005,33 : 313- 315.
  • 7Hartung T, Balls M, Bardouille C, et al. Good cell culture practice. Alter Lab Animal ,2002,30:407-414.
  • 8Li Y, Powell S, Brunette E, et al Expansion of human embry- onic stem cells in defined serum free medium devoid of ani- mal-derived products. Biotechnol Bioeng ,2005 ,91:688-698.
  • 9Huang YM, Hu W, Rustandi E, et al. Maximizing productivity of CHO cell-based fed-batch culture using chemically de- fined media conditions and typical manufacturing equipment. Biotechnol Prog ,2010 ,26 : 1400-1410.
  • 10Hgidemann R, Zhang C, Qi HS, et al. The use of peptones as medium additives for the production of a recombinant thera- peutic protein in high density perfusion cultures of mammali- an cells. Cytotechnology,2000,32 : 157-167.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部